National Thrombosis Seminars

CanVECTOR is proud to announce the launch of the inaugural CanVECTOR National Thrombosis Seminar series: live, monthly, virtual webinars featuring state-the-art thrombosis / venous thromboembolism (VTE) lectures presented by both Canadian and international experts!

The 2020-2021 series will run from September 2020-April 2021. Each webinar will be free to register and attendees are eligible for CME credits as the CanVECTOR National Thrombosis Seminars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

2020-2021 Program Schedule

  • September 21, 2020
  • November 24, 2020
  • January 28, 2021
  • February 24, 2021
  • March 24, 2021
  • April 2021 (TBD)

Next Webinar

  

Previous Seminars

Maternal Health & VTE

Wednesday, February 24, 2021 - 11:00-12:00pm (EST)

Program and Speakers

Speakers

  • Prof. Patricia Maguire, PhD, Professor, School of Biomolecular and Biomedical Science at University College Dublin
    • Presentation:  PALADIN: Investigating Platelets in health and disease
  • Dr. Leslie Skeith, M.D., M.Sc., FRCPC, Clinical Assistant Professor in the Division of Hematology & Hematological Malignancies at University of Calgary
    • Presentation: Postpartum Thromboprophylaxis: Rationale for the Pilot PARTUM Trial.

Featuring a 15 minute Q&A following the presentations. 

Learning Objectives

  1. Recognize that the platelet releasate contains soluble and vesicular cargo.
  2. Describe the PALADIN (PlAteLet-bAsed DIagNositics) platform that uses platelets to understand health and disease
  3. Interpret AI_PREMie, a novel AI-based solution for the diagnosis and risk stratification of preeclampsia
  4. Assess how placing powerful machine learning into the hands of basic scientists and clinicians can transform diagnostic solutions for chronic diseases
  5. Review the risk of postpartum VTE and associated risk factors 
  6. Describe available evidence for postpartum thromboprophylaxis
  7. Review the rationale and updates for the pilot PARTUM trial

View Video

 

Statins & VTE Research

Thursday, January 28, 2021 - 2:30-3:30 pm (EST)

Program / Speakers

 

Speakers

  • Dr. Aurélien Delluc, MD, PhD, Professor of medicine and a scientific clinician in the Department of Medicine, Division of Hematology at the University of Ottawa.
    • Presentation: Do statins prevent VTE?
  • Dr. Peter Gross, M.D., M.Sc., FRCPC, Associate Professor, Department of Medicine, Division of Hematology and Thromboembolism at McMaster University and the Head of the Clinical Thrombosis Service at Hamilton Health Sciences.
    • Presentation: Pleomorphic properties of Statins - Might they alter DVT and post-thrombotic syndrome?

Featuring a 15 minute Q&A following the presentations. 

Learning Objectives

  1. To review the association between statins and risk for VTE and recurrent VTE
  2. To discuss future clinical studies on statins in VTE
  3. Understand how statins might have effects other than lowering cholesterol
  4. Appreciate the limitations of models of deep vein thrombosis and post-thrombotic syndrome.

View Video

Malignancy Screening in Patients with Unprovoked VTE

Thursday, November 24, 2020 - 12:00-1:00 pm (EST)

Program / Speakers

 

Speakers

  • Dr. Marc Carrier, Head of the Division of Hematology in the Department of Medicine at The Ottawa Hospital, a Professor in the Faculty of Medicine, University of Ottawa.
    • Presentation: Screening for cancer in unprovoked venous Thromboembolism (VTE).
  • Dr. Patricia Liaw, Professor in the Department of Medicine, Division of Hematology and Thromboembolism,  McMaster University.
    • Presentation: Mechanisms of Thrombosis in Cancer Patients.

Featuring a 15 minute Q&A following the presentations. 

Learning objectives

  • Describe the rates of occult cancer detection following venous thromboembolism (VTE).
  • Discuss risk stratification and future occult cancer screening diagnostic modalities for patients with unprovoked VTE.
  • Select appropriate occult cancer screening strategies (limited vs. extended) in this patient population.
  • Describe how Virchow’s triad contributes to thrombosis in cancer patients
  • Describe how anti-cancer therapies contribute to the hypercoagulable state in cancer patients
  • Describe how immune cells promote thrombosis in the setting of cancer

 

View Video 

COVID-19-VTE Research

Monday, September 21, 2020 - 1200-1:00 pm (EST)

Program / Speakers

 

Keynote Speaker

  •  Dr. Agnes Lee, Medical Director of the Thrombosis Program and Professor of Medicine at University of British Columbia, Canada
    • Presentation: COVID-19 and Thrombosis – Concept of Immunothrombosis

Featuring the two winners of the CanVECTOR COVID-19 VTE-Related Rapid Funding competition:

  • Dr. Tobias Tritschler, General Internal Medicine physician at University of Bern, Switzerland
    • Presentation: Anticoagulation in hospitalized patients with COVIDÔÇÉ19: an individual patient data network meta-analysis of randomized controlled trials
  • Dr. Edward Conway, Director of the Centre for Blood Research and Professor of Department of Medicine at University of British Columbia, Canada
    • Presentation: The role of complement in SARS-CoV-2-triggered thrombosis

Featuring a 15 minute Q&A following the presentations. 

Learning Objectives 

  • To review the incidence of VTE in COVID-19
  • To introduce the concept of immunothrombosis
  • To understand the potential role of immunothrombosis in COVID-19

View Video